Atricure to announce fourth quarter and full year 2023 financial results and participate in 2024 btig medical technology conference

Mason, ohio--(business wire)--atricure, inc. (nasdaq: atrc), a leading innovator in surgical treatments and therapies for atrial fibrillation (afib), left atrial appendage (laa) management, and post-operative pain management, today announced that it will release its fourth quarter and full year 2023 financial results on thursday, february 15, 2024. atricure will host an audio webcast at 4:30 p.m. eastern time on thursday, february 15, 2024, to discuss its fourth quarter and full year 2023 finan.
ATRC Ratings Summary
ATRC Quant Ranking